肠外营养市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00005217
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 154
Buy Now

【研究报告】2022年肠外营养市场规模为68.4亿美元,预计到2030年将达到111.2亿美元;预计 2022 年至 2030 年市场复合年增长率为 6.0%。
市场洞察和分析师观点:
肠外营养是一种静脉注射的营养补充剂,包括液体、维生素、矿物质、微量元素、氨基酸酸和电解质。与肠内(胃或肠道)喂养相比,肠外营养更复杂、更昂贵,并且感染风险更高,住院时间更长。只有无法接受肠内营养的患者才会接受肠外营养。肠外营养治疗的目标包括恢复营养状态、治疗低蛋白血症、修复肌肉无力和替代其他营养缺陷。胃肠道疾病患病率上升以及营养不良和早产病例激增等因素推动了肠外营养市场的增长。
增长动力和挑战:
克罗恩病、肠梗阻、溃疡性结肠炎、短肠综合症、显微镜下结肠炎和胃癌是胃肠道疾病的几个例子。根据 2021 年 1 月发布的“罗马基金会全球研究结果,功能性胃肠道疾病的全球患病率和负担”,功能性胃肠道疾病影响了全球超过 40% 的人。根据2019年全球疾病负担研究,2019年全球记录了约490万例炎症性肠病(IBD)病例。中国(911,405例)和美国(762,890例)的病例数最多,患病率分别为66.9和245.3分别为每 10 万人中的病例数。溃疡性结肠炎和克罗恩病是两种常见的 IBD。克罗恩病是一种复杂的慢性疾病,主要影响消化系统。它是北美和欧洲最常见的疾病。英国克罗恩病和结肠炎组织进行的研究表明,到 2022 年,英国每 123 人中约有 1 人患有克罗恩病或溃疡性结肠炎,约占英国患有 IBD 的人数约 50 万人。此外,每年每 100 万人中约有 3 人患有短肠综合症 (SBS)。根据 2020 年发表的题为“了解短肠综合症:现状和未来展望”的文章,短肠综合症 (SBS) 的患病率在过去 40 年中增加了两倍多。患病率约为每人 30 例。美国有 100 万人,欧洲约有 1.4 例。
患有胃肠道疾病的患者营养恶化的风险较高,因为他们被要求在接受诊断测试之前禁食。他们还可能因治疗性饮食而面临营养恶化由于厌食或营养需求改变而导致的食欲限制和食欲不振,这可能是由疾病本身造成的。因此,对于胃肠道疾病患者,由于他们无法摄取食物,建议进行医学营养。此外,优选肠外途径有些人可能无法表现出与插管的相容性,这使得满足他们的卡路里和营养需求变得困难。在这种情况下,优选肠外营养,以确保他们的身体保持水分并满足维持身体健康和功能所需的热量和其他营养摄入量。当患者因被诊断患有影响胃肠道的癌症和慢性疾病等疾病而无法满足营养需求时,需要肠外营养。对于大多数患有严重 SBS 的患者来说,这种类型的营养是高度首选的治疗选择。因此,胃肠道疾病的日益流行推动了肠外营养市场的增长。
营养产品配方的创新预计将在未来几年带来新的肠外营养市场趋势。然而,与肠外营养相关的主要问题包括血流和静脉导管的感染。血液的感染主要是由于消化道不用时的萎缩造成的。与导管放置相关的并发症包括感染、闭塞、中心静脉血栓(CVT)、肺栓塞(PE)和破裂。静脉导管周围的血管血栓(血栓形成)是静脉治疗和静脉营养的另一个潜在并发症。导管闭塞可能是机械性阻塞、静脉注射脂肪溶液或沉淀物造成的。与肠外营养相关的其他并发症包括高血糖和高甘油三酯血症,这影响着全世界大量的患者群体。接受过量的葡萄糖(由于过度喂养)或接受静脉注射脂质的快速输注会导致高甘油三酯血症。因此,与肠外营养相关的并发症可能导致死亡率和与导管放置相关的限制,阻碍了肠外营养市场。
战略见解
报告细分和范围:
“肠外营养市场分析”已被通过考虑以下部分来进行:营养素类型和最终用户。按营养类型划分,市场分为单剂量氨基酸溶液、肠外脂肪乳、碳水化合物、微量元素以及维生素和矿物质。根据最终用户,市场分为医院、诊所等。
细分分析:
肠外营养市场按营养类型分为单剂量氨基酸溶液、肠外脂肪乳、碳水化合物、微量元素、维生素和矿物质。碳水化合物、肠外脂肪乳、单剂量氨基酸溶液、微量元素、维生素和矿物质。 2022年,单剂量氨基酸溶液领域主导肠外营养市场份额;在预测期内,肠外脂肪乳细分市场的复合年增长率可能最高。人们越来越需要营养疗法,例如肠外氨基酸,它可以提供大量蛋白质,但不会提供有毒量的能量,以减缓危重患者的蛋白质分解代谢。氨基酸补充是在健康个体氨基酸摄入不足以及特定生理或病理生理情况下对患者进行氨基酸补充。肠外喂养的婴儿和儿童的氨基酸需求量低于肠内喂养的婴儿,因为供应绕过肠道。
肠外营养市场,按营养类型 - 2022 年和 2030 年
就最终用户而言,肠外营养市场分为医院、诊所和其他。 2022 年,医院细分市场占据最大市场份额;然而,预计 2022 年至 2030 年,临床细分市场的复合年增长率将是肠外营养市场最高的。医院被认为是拥有所有可用设施的最大实体。医院还提供各种诊断和治疗设施,这些设施可以根据保险索赔进行报销。医院与各种医生、专科医生和其他提供增强医疗服务的专业人员有联系。所有类型的心血管疾病都可以在医院治疗。医院通过为患有各种疾病的患者提供广泛的医疗服务(包括护理服务)而发挥着重要作用。这增加了医院患者对多种疾病和手术的透皮给药系统的采用。
区域分析:
肠外营养市场报告的范围主要分为北美(美国、加拿大和墨西哥) )、欧洲(西班牙、英国、德国、法国、意大利和欧洲其他地区)、亚太地区(韩国、中国、印度、日本、澳大利亚和亚太地区其他地区)、中东和非洲(南非)非洲、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。
2022 年,就收入而言,北美洲美国在肠外营养市场份额中占据主导地位。美国在该地区占有最大的市场份额。癌症、心脏病和其他慢性疾病是美国残疾和死亡的主要原因。根据国家慢性病预防和健康促进中心的数据,该国每 10 人中有 6 人被诊断患有至少一种慢性病。此外,美国医院协会估计约有 1.33 亿人至少患有一种慢性病,预计到 2030 年这一数字将达到 1.7 亿。根据 2019 年 1 月发表的一篇题为“肠外营养趋势”的文章;在美国,平均每年约有 34,000 名患者接受肠外营养 (PN)。肠内管饲可用于治疗 350 多种儿童疾病和医疗状况。
政府通过宣传计划提高人们对肠内和肠外营养的认识,进一步推动了美国肠外营养市场的增长。例如,饲管意识基金会提高了人们对采用饲管作为救生医疗干预措施的认识,并帮助管饲儿童的父母。该基金会于 2019 年 2 月 4 日至 2 月 8 日庆祝了年度饲管意识周。
亚太地区预计在 2022 年至 2030 年期间复合年增长率最高。由于该地区主要市场参与者的不断增加以及慢性病患病率的不断上升,亚太地区肠外营养市场预计将增长。由于这些因素,该地区的肠外营养产品产量最高。由于医疗保健行业在预测期内不断发展,澳大利亚、印度、韩国和该地区的其他一些国家预计将出现各种增长机会。此外,这些国家的政府正在加大力度提供肠外营养。
竞争格局和主要公司:
肠外营养市场报告重点关注市场上的知名企业,如 ICU Medical Inc、Grifols SA、辉瑞公司、大冢制药有限公司、百特国际公司、B Braun SE、Fresenius Kabi AG、四川科伦生物制药有限公司、Vifor Pharma Management AG 和 Aculife Healthcare Pvt Ltd。肠外营养市场预测可以帮助利益相关者规划其增长策略。这些公司专注于新技术、升级现有产品和地域扩张,以满足全球不断增长的消费者需求。
2022 年 12 月,Baxter International Inc 在美国推出了 ExactaMix Pro 自动混炼机。该产品于 2023 年初首次亮相。最近发布的产品利用尖端复合技术来提高患者安全、工艺有效性和配方准确性。
2022 年 10 月,贝朗 SE 展示了其宏观和微观复合机、APEX 混配系统及其专有的 TPN Manager 临床决策支持订单输入软件。为了减少沉淀的机会,TPN Manager 程序包括 Trissel 的 Ca/P 检查,使用户能够创建模板来标准化其订单格式。
2022 年 3 月,Fresenius Kabi AG 的 SMOFlipid 脂质注射剂获得 FDA 批准乳液。该注射剂适用于儿科患者,包括美国的足月和早产新生儿。该产品是第一个也是唯一一个适用于各个年龄段肠外营养患者的四油脂肪乳。 SMOFlipid 可在所有设施中心使用。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region is the fastest growing the parenteral nutrition market?

Asia Pacific is expected to be the fastest growing region in the parenteral nutrition market. The parenteral nutrition market in Asia Pacific is expected to grow owing to the growing presence of major market players across the region and the increasing prevalence of chronic diseases. Due to these factors, the region records the highest manufacturing of parenteral nutrition products. Australia, India, South Korea, and a few other countries in the region are estimated to witness various growth opportunities due to the growing development in the healthcare sector during the forecast period.

Which end user segment is dominating the parenteral nutrition market?

The parenteral nutrition market by end user is categorized into hospitals, clinics, and others. The hospitals segment anticipated to hold a significant parenteral nutrition market share by 2030; however, the clinic segment likely to register the highest CAGR in the parenteral nutrition market during 2022–2030.

Which nutrient type segment is dominating the parenteral nutrition market?

The parenteral nutrition market, based on nutrient type, is segmented into rbohydrates, parenteral lipid emulsion, single dose amino acid solution, trace elements, and vitamins and minerals. The parenteral nutrition market analysis estimated that the single dose amino acid solution segment held the largest share of the market in 2022; and the parenteral lipid emulsion segment is likely to register the highest CAGR in the parenteral nutrition market during 2022–2030.

Which country is dominated the parenteral nutrition market?

US holds the largest market share in parenteral nutrition market. Cancer, heart disease, and other chronic diseases are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country are diagnosed with at least one chronic disease. Additionally, the American Hospital Association estimates that ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030.

What are the driving factors for the parenteral nutrition market across the globe?

The factors that are driving growth of the market are the rise in prevalence of gastrointestinal diseases and surge in cases of malnutrition and premature births.

Who are the major players in the parenteral nutrition market?

The parenteral nutrition market majorly consists of the players such as ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, Vifor Pharma Management AG, and Aculife Healthcare Pvt Ltd. among others.

What is parenteral nutrition?

Parenteral nutrition is a type of nutritional supplementation administered intravenously that includes fluids, vitamins, minerals, trace elements, amino acids, and electrolytes. Compared to enteral (gastric or intestinal) feeding, parenteral nutrition is more complex, more costly, and linked to a higher risk of infection and longer hospital stays. Only patients who are unable to receive nutrition enterally are prescribed parenteral nutrition. The goals of parenteral nutrition therapy include restoring nutritional status, treating hypoproteinemia, fixing muscle weakness, and replacing other nutritional deficits.

The List of Companies - Parenteral Nutrition Market

  1. ICU Medical Inc   
  2. Grifols SA               
  3. Pfizer Inc                
  4. Otsuka Pharmaceuticals Co Ltd
  5. Baxter International Inc   
  6. B Braun SE             
  7. Fresenius Kabi AG              
  8. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd  
  9. Vifor Pharma Management AG
  10. Aculife Healthcare Pvt Ltd            

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports